Fractional flow reserve and the index of microvascular resistance in patients with acute coronary syndromes

EuroIntervention

Volumn 10, Issue t, 2014, Pages T55-T63

  Hennigan, Barry ^a   Layland, Jamie ^b   Fearon, William F ^c   Oldroyd, Keith G ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

^c Divisions of Cardiovascular Medicine   (United States)

Author keywords

Acute coronary syndrome; Coronary physiology; Fractional flow reserve; Index of myocardial resistance

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY RECANALIZATION; FRACTIONAL FLOW RESERVE; HUMAN; MEDICAL DECISION MAKING; MYOCARDIAL RESISTANCE INDEX; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; VASCULAR RESISTANCE; ANGIOCARDIOGRAPHY; MICROVASCULATURE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ACUTE CORONARY SYNDROME; CORONARY ANGIOGRAPHY; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MICROVESSELS; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR RESISTANCE;

EID: 84928469077     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10STA10     Document Type: Article

References (36)

1. Puymirat E, Muller O, Sharif F, Dupouy P, Cuisset T, de Bruyne B, Gilard M. Fractional flow reserve: concepts, applications and use in France in 2010. Arch Cardiovasc Dis. 2010;103:615-22.
2. Legalery P, Schiele F, Seronde MF, Meneveau N, Wei H, Didier K, Blonde MC, Caulfield F, Bassand JP. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J. 2005;26:2623-9.
3. Lekston A, Tajstra M, Gasior M, Gierlotka M, Pres D, Hudzik B, Trzeciak P, Kalarus Z, Poloński L , Zembala M. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Kardiol Pol. 2011;69:336-43.
4. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and non-infarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am J Cardiol. 2010;106:342-7.
5. Dellavalle A, De Servi S, Repetto S, Chierchia S, Repetto A, Vado A, Steffenino G. Coronary angioplasty in patients with unstable angina: clinical, electrocardiographic and angiographic predictors of in-hospital outcome. R.OS.A.I. Study Group. Ital Heart J. 2000;1:555-61.
6. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994;89:1545-56.
7. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Lancet. 1999;354:708-15.
8. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999-3054.
9. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-619.
10. Toma M, Buller CE, Westerhout CM, Fu T, O'Neill WW, Holmes DR Jr, Hamm CW, Granger CB, Armstrong PW; APEX-AMI Investigators. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J. 2010;31:1701-7.
11. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assalli A, Claessen BE, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, Dudek D, Fahy M, Lansky AJ, Stone GW; HORIZONS-AMI Trial Investigators. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011;58:704-11.
12. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, Berry C, Oldroyd KG; PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115-23.
13. Garcia-Garcia HM, Jang IK, Serruys PW, Kovacic JC, Narula J, Fayad ZA. Imaging plaques to predict and better manage patients with acute coronary events. Circ Res. 2014;114:1904-17.
14. Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. Am J Cardiol. 2004;15:178-81.
15. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol. 1993;22:650-8.
16. Pizzuto F, Voci P, Mariano E, Puddu PE, Spedicato P, Romeo F. Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease. Am J Cardiol. 2004;94:577-82.
17. Tamita K, Akasaka T, Takagi T, Yamamuro A, Yamabe K, Katayama M, Morioka S, Yoshida K. Effects of microvascular dysfunction on myocardial fractional flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction. Catheter Cardiovasc Interv. 2002;57:452-9.
18. Wood DA, Poulter R, Boone R, Owens C, Starovoytov A, Lim I, Bogale N, Lempereur M, Shiekh I, Buller C, Humphries K, Mancini G, Cairns J, Wong G. Stability of Non Culprit Vessel Fractional Flow Reserve in Patients With St-Segment Elevation Myocardial Infarction. Can J Cardiol. 2013;29:S291-2.
19. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157-62.
20. Potvin JM, Rodés-Cabau J, Bertrand OF, Gleeton O, Nguyen CN, Barbeau G, Proulx, G, De Larochellière R, Déry JP, Batalla N, Dana A, Facta A, Roy L. Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or atypical chest pain. Am J Cardiol. 2006;98:289-97.
21. Samady H, Lepper W, Powers ER, Wei K, Ragosta M, Bishop GG, Sarembock IJ, Gimple L, Watson DD, Beller GA, MD, Barringhaus KG. Fractional flow reserve of infarct-related arteries identifies reversible defects on noninvasive myocardial perfusion imaging early after myocardial infarction. J Am Coll Cardiol. 2006;47:2187-93.
22. Ntalianis, A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, Barbato E, Hamilos M, Mangiacapra F, Heyndrickx GR, Wijns W, Pijls NH, De Bruyne B. Fractional flow reserve for the asessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274-81.
23. Layland J, Carrick D, McEntegart M, Ahmed N, Payne A, McClure J, Sood A, McGeoch R, MacIsaac A, Whitbourn R, Wilson A, Oldroyd K, Berry C. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-STsegment-elevation myocardial infarction. Circ Cardiovasc Interv. 2013;6:231-6.
24. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG. Prognostic Value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436-41.
25. Cuculi F, Dall'armellina E, Manlhiot C, De Caterina AR, Colyer S, Ferreira V, Morovat A, Prendergast BD, Forfar JC, Alp NJ, Choudhury RP, Neubauer S, Channon KM, Banning AP, Kharbanda RK. Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction. Eur Heart J. 2013 Oct 17. [Epub ahead of print]
26. Pim AL, Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary angiography. N Engl J Med. 2009;360:213-24.
27. Sels JW, Tonino PA, Siebert U, Fearon WF, Van't Veer M, De Bruyne B, Pijls NH. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. 2011;4:1183-9.
28. Lopez-Palop R, Carrillo P, Torres F, Lozano I, Frutos A, Avanzas P, Cordero A, Rondan J. Results of fractional flow reserve measurement to evaluate nonculprit coronary artery stenoses in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2012;65:164-70.
29. Carrick D, Behan M, Foo F, Christie J, Hillis WS, Norrie J, Oldroyd KG, Berry C. Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol. 2013;111:45-50.
30. Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, Champagne S, Belle L, Barreau D, Hanssen M, Besnard C, Dauphin R, Dallongeville J, El Hahi Y, Sideris G, Bretelle C, Lhoest N, Barnay P, Leborgne L, Dupouy P; Investigators of the Registre Français de la FFR - R3F. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129:173-85.
31. Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD. (CompareAcute). From ClinicalTrials.gov (NCT01399736).
32. Complete vs Culprit-only Revascularization to Treat Multivessel Disease After Primary PCI for STEMI (COMPLETE). From ClinicalTrials.gov (NCT01740479).
33. Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization (PRIMULTI). From ClinicalTrials.gov (NCT01960933).
34. Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes (FAMOUS NSTEMI). From ClinicalTrials.gov (NCT01764334).
35. Aung Naing K, Li L, Su Q, Wu T. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database Syst Rev. 2013; 6: CD009503. doi: 10.1002/14651858.CD009503. pub2.
36. Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: Physiology, Pharmacology, and Clinical Applications. JACC Cardiovasc Interv. 2014;7:581-591.